Eterna Therapeutics Inc (ERNA) concluded trading on Wednesday at a closing price of $0.32, with 0.44 million shares of worth about $0.14 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -82.33% during that period and on January 08, 2025 the price saw a loss of about -3.03%. Currently the company’s common shares owned by public are about 51.37M shares, out of which, 48.88M shares are available for trading.
Stock saw a price change of 9.97% in past 5 days and over the past one month there was a price change of -19.15%. Year-to-date (YTD), ERNA shares are showing a performance of 9.97% which decreased to -83.16% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.22 but also hit the highest price of $2.62 during that period. The average intraday trading volume for Eterna Therapeutics Inc shares is 857.68K. The stock is currently trading 10.78% above its 20-day simple moving average (SMA20), while that difference is down -43.56% for SMA50 and it goes to -77.94% lower than SMA200.
Eterna Therapeutics Inc (NASDAQ: ERNA) currently have 51.37M outstanding shares and institutions hold larger chunk of about 1.38% of that.
The stock has a current market capitalization of $16.61M and its 3Y-monthly beta is at 4.32. It has posted earnings per share of -$8.31 in the same period. It has Quick Ratio of 0.48. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ERNA, volatility over the week remained 18.83% while standing at 16.29% over the month.
